Publication:
Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)

Simple item page
dc.contributor.authorYOLDEMİR, AHMET TEVFİK
dc.contributor.authorsOzyurek, Eser Sefik; Yoldemir, Tevfik; Artar, Gokhan
dc.date.accessioned2022-03-02T05:38:47Z
dc.date.accessioned2026-01-11T06:55:39Z
dc.date.available2022-03-02T05:38:47Z
dc.date.issued2017-12
dc.identifier.doi10.1186/s13048-017-0330-7
dc.identifier.issn1757-2215
dc.identifier.issue1
dc.identifier.pages34
dc.identifier.urihttps://hdl.handle.net/11424/218501
dc.identifier.volume10
dc.language.isoeng
dc.relation.urihttp://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-017-0330-7
dc.titleAndrostenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)
dc.title.alternativeAndrostenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
697.01 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları